Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

NUVEEN CHURCHILL DIRECT LENDING CORP. COMMON STOCK (NCDL)

  • SEC News
  • May 07, 2026, 11:17 UTC
  • 3
  • 1 comments

(99% Neutral) NUVEEN CHURCHILL DIRECT LENDING CORP. COMMON STOCK (NCDL) Reports Q2 2026 Financial Results

Comment Full text

BLACK DIAMOND THERAPEUTICS, INC. (BDTX)

  • SEC News
  • May 07, 2026, 11:17 UTC
  • 3
  • 1 comments

(30% Negative) BLACK DIAMOND THERAPEUTICS, INC. (BDTX) Reports Q2 2026 Financial Results

Comment Full text

MADISON SQUARE GARDEN ENTERTAINMENT CORP. (MSGE)

  • SEC News
  • May 07, 2026, 11:16 UTC
  • 3
  • 1 comments

(30% Negative) MADISON SQUARE GARDEN ENTERTAINMENT CORP. (MSGE) Reports Q2 2026 Financial Results

Comment Full text

GPGI, INC. (GPGI)

  • SEC News
  • May 07, 2026, 11:15 UTC
  • 3
  • 1 comments

(69% Positive) GPGI, INC. (GPGI) Announces Business Combination

Comment Full text

XERIS BIOPHARMA HOLDINGS, INC. (XERS)

  • SEC News
  • May 07, 2026, 11:15 UTC
  • 3
  • 1 comments

(30% Negative) XERIS BIOPHARMA HOLDINGS, INC. (XERS) Reports Q2 2026 Financial Results

Comment Full text

RESOLUTE HOLDINGS MANAGEMENT, INC. (RHLD)

  • SEC News
  • May 07, 2026, 11:15 UTC
  • 3
  • 1 comments

(35% Negative) RESOLUTE HOLDINGS MANAGEMENT, INC. (RHLD) Reports Q2 2026 Financial Results

Comment Full text

OPPFI INC. (OPFI)

  • SEC News
  • May 07, 2026, 11:15 UTC
  • 3
  • 1 comments

(99% Positive) OPPFI INC. (OPFI) Reports Q2 2026 Financial Results

Comment Full text

ACLARIS THERAPEUTICS, INC. (ACRS)

  • SEC News
  • May 07, 2026, 11:15 UTC
  • 3
  • 1 comments

(30% Negative) ACLARIS THERAPEUTICS, INC. (ACRS) Reports Q2 2026 Financial Results

Comment Full text

GP-ACT III ACQUISITION CORP. (GPATW)

  • SEC News
  • May 07, 2026, 11:15 UTC
  • 3
  • 1 comments

(75% Positive) GP-ACT III ACQUISITION CORP. (GPATW) Announces Business Combination

Comment Full text

RAPPORT THERAPEUTICS, INC. (RAPP)

  • SEC News
  • May 07, 2026, 11:15 UTC
  • 3
  • 1 comments

(30% Negative) RAPPORT THERAPEUTICS, INC. (RAPP) Reports Q2 2026 Financial Results

Comment Full text
  • Previous
  • 1200
  • 1201
  • 1202
  • 1203
  • 1204
  • Next

Search

News categories

  • Technical Exchange News(12475)
  • Event(6229)
  • SEC News(281878)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(161462)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin